Earnest Partners LLC Emergent Bio Solutions Inc. Transaction History

Earnest Partners LLC

$22.1 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$27.42 - $43.63 $6.22 Million - $9.89 Million	-226,755 Reduced 10.95%	1,844,621 $57.3 Million
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $4.28 Million - $6.12 Million	-117,230 Reduced 5.36%	2,071,376 $85.1 Million
Q4 2021 Feb 07, 2022	SELL	$33.11 - $55.01 $1.61 Million - $2.67 Million	-48,575 Reduced 2.17%	2,188,606 $95.1 Million
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $5.79 Million - $7.64 Million	115,637 Added 5.45%	2,237,181 $112 Million
Q2 2021 Aug 16, 2021	BUY	$56.61 - $80.46 $37.4 Million - $53.1 Million	660,477 Added 45.21%	2,121,544 $134 Million
Q1 2021 May 17, 2021	BUY	$86.23 - $125.19 $6.06 Million - $8.8 Million	70,332 Added 5.06%	1,461,067 $136 Million
Q4 2020 Feb 16, 2021	SELL	$79.17 - $111.47 $321,351 - $452,456	-4,059 Reduced 0.29%	1,390,735 $125 Million
Q3 2020 Nov 16, 2020	SELL	$81.91 - $134.94 $12.1 Million - $19.9 Million	-147,430 Reduced 9.56%	1,394,794 $144 Million
Q2 2020 Aug 13, 2020	SELL	$54.33 - $89.52 $67.4 Million - $111 Million	-1,240,552 Reduced 44.58%	1,542,224 $122 Million
Q1 2020 May 14, 2020	BUY	$49.34 - $68.76 $36.9 Million - $51.4 Million	747,724 Added 36.74%	2,782,776 $161 Million
Q4 2019 Feb 07, 2020	BUY	$51.21 - $59.06 $14.8 Million - $17.1 Million	289,599 Added 16.59%	2,035,052 $110 Million
Q3 2019 Nov 14, 2019	BUY	$40.6 - $57.2 $2.16 Million - $3.05 Million	53,282 Added 3.15%	1,745,453 $91.3 Million
Q2 2019 Aug 13, 2019	BUY	$39.92 - $53.86 $60.5 Million - $81.7 Million	1,516,013 Added 860.6%	1,692,171 $81.7 Million
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $8.5 Million - $11.7 Million	176,158 New	176,158 $8.9 Million
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $22,641 - $29,808	-407 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$37.77 - $47.75 $15,372 - $19,434	407	407 $19,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$32.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$28.6 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$18.7 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Earnest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Earnest Partners LLC with notifications on news.

Account